InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Discover the complete record of transactions filed by Dukes Iain D.. Director active across 3 companies, notably Iovance Biotherapeutics, INC.. In total, 6 reports have been recorded. Split: 2 buys · 0 sell. Total volume traded: €331k. History available since 23 November 2022. The latest transaction was disclosed on 12 December 2025 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
6 of 6 declarations
Dukes Iain D. is a declarant with 6 filings in total. In the recent filings observed, they span from 2022-11-28 to 2025-12-16, with EUR 330890 of buys and EUR 0 of sells, and the most frequent transaction nature is Attribution. They are Chief Executive Officer at Traws Pharma, Inc., Director at Iovance Biotherapeutics, INC., and Director at Theseus Pharmaceuticals, Inc.